Physician profile
Dwight E Mosley
NPI 1033386982
$7,724.22
in general payments reported to CMS, 2019-2025
34 companies · $352 in 2025
The $352 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,904 · 2020: $710 · 2021: $663 · 2022: $2,623 · 2023: $859 · 2024: $614 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,824.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,472.02 | 2019-2025 | General - Therapies, Wavewriter Alpha Prime 16, General - Pain Management |
| Spinal Simplicity, LLC | $1,181.88 | 2022-2023 | Ha Minuteman G3-R |
| Abbott Laboratories | $984.21 | 2019-2023 | Proclaim |
| Medtronic, INC. | $904.64 | 2021-2024 | Intellis Adaptivestim, Anteralign Spinal System With Titan Nanolock Surface Technology |
| Medtronic USA, INC. | $665.66 | 2019-2020 | |
| Pfizer INC. | $611.58 | 2019-2021 | |
| Nalu Medical, INC. | $398.60 | 2021-2023 | Nalu Neurostimulation System |
| Collegium Pharmaceutical, INC. | $381.46 | 2019-2025 | Xtampza, Belbuca |
| Biodelivery Sciences International, INC. | $120.03 | 2020-2021 | |
| Zyla Life Sciences, INC. | $115.91 | 2019 | |
| Stimwave Technologies Incorporated | $94.04 | 2019-2022 | |
| Horizon Therapeutics Plc | $89.26 | 2019-2022 | |
| Abbvie INC. | $73.33 | 2022-2023 | |
| Arbor Pharmaceuticals, INC. | $66.32 | 2020-2022 | |
| Amgen INC. | $47.85 | 2019-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $47.15 | 2021-2022 | |
| Si-Bone, INC. | $45.71 | 2019-2025 | |
| Nevro Corp. | $41.31 | 2020-2024 | Senza |
| Curonix LLC | $40.48 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Globus Medical, INC. | $37.95 | 2024 | Affirm, Si-Lok |
| Scilex Pharmaceuticals INC. | $36.90 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.44 | 2019-2020 | |
| Daiichi Sankyo INC. | $32.87 | 2019 | |
| Painteq LLC | $30.17 | 2023-2024 | Painteq |
| Foundation Fusion Solutions, LLC | $29.49 | 2022 | |
| Biotronik Nro, INC. | $18.40 | 2025 | Prospera |
| Kowa Pharmaceuticals America, INC. | $17.38 | 2022 | |
| Averitas Pharma INC. | $16.79 | 2024 | Qutenza |
| Protega Pharmaceutials INC | $16.47 | 2022 | |
| Mml US, INC. | $15.61 | 2023 | Reactiv8 |
| Kaleo, INC. | $15.45 | 2019 | |
| Vertos Medical, INC. | $13.91 | 2024 | Mild Device Kit |
| Mdd US Operations, LLC | $12.93 | 2019 | |
| Vertical Pharmaceuticals, LLC | $12.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dwight Mosley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.